We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Alphabet to Create Google Maps for Healthcare

By HospiMedica International staff writers
Posted on 09 May 2017
Verily, formerly known as Google Life Sciences, is launching Project Baseline, a four-year longitudinal health study designed to understand how people transition from being healthy to becoming sick, and to identify additional risk factors for diseases.

Together with Duke University and Stanford University, Verily will enroll 10,000 volunteers from diverse backgrounds at half a dozen study sites in California and North Carolina. More...
Study participants will wear the Verily-developed Study Watch health tracker and will also have their genomes sequenced. Molecular indicators, such as microbiome and proteomics, will also be studied. The Baseline researchers are hoping that the sleep, activity, heart rate, genomics and other data will help identify find early warning signs for disease.

The Study Watch, which will be worn by participants on a daily basis, includes multiple physiological and environmental sensors designed to measure health data, including electrocardiogram (ECG), heart rate, electrodermal activity, and inertial movements. The watch has a long battery life of up to one week in order to improve user compliance. And large internal storage capacity and data compression will allow it to store weeks’ worth of raw data, thus relaxing the need for frequent synchronization. The firmware is also designed to be robust for future extensions, such as over-the-air updates, new algorithms, and user interface upgrades.

Because the investigational device stores health data, all data are encrypted, uploaded, and processed in the cloud using backend algorithms and machine learning tools. The infrastructure is highly scalable and can serve future population studies consisting of large volumes of data. The low power, high-resolution display is always on for an appealing look and a robust user interface. Currently, only time and certain instructions are displayed, with no other information provided back to the user.

“The Project Baseline study has the opportunity to significantly influence our current body of knowledge by better understanding the indicators of wellness,” said Nancy Brown, CEO of the American Heart Association (AHA). “The outcome of this study could inspire a new generation of tools that are geared towards disease prevention, versus just diagnosis and treatment.”

The Baseline Project is modeling itself on prior efforts, like the Framingham Heart Study, which kicked off in the late 1940s with more than 5,000 participants. The results of that study showed the importance of regular exercise and a healthy diet in maintaining good health, as well as the deleterious effects of smoking.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.